Pierachille Santus - Concepedia

Author

Pierachille Santus

Also Known As

Ayman GRADA, Dejan Radovanovic, Dennis M. LINDER, Giuliano Rizzardini, P SANTUS, P Santus, P. SANTUS, P. Santus, P.A. Santus, PierAchille Santus

311

Publications

8.1K

Citations

H-Index

135

Concepts

All Affiliations

University of Milan Ospedale San Paolo ASST Fatebenefratelli Sacco Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Istituti di Ricovero e Cura a Carattere Scientifico

About

Pierachille Santus is an author at University of Milan specializing in medicine, pulmonary disease, and pulmonary medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	60	4.2K
2	Health Sciences	8	8	593
3	Public Health	7	7	357
4	Engineering	1	1	17
5	Nursing	1	1	186

Pierachille Santus

103

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
Anxiety and depression in COPD patients: The roles of gender and disease severity Fabiano Di Marco, Massimo Verga, Manuela Reggente, Respiratory Medicine Psychological Co-morbiditiesPsychopathologyPsychiatryDisease SeverityComorbid Psychiatric Disorder	2006	477
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection Laura Montefusco, Moufida Ben Nasr, Francesca D’Addio, Nature Metabolism Glycometabolic ControlLong CovidViral PersistenceImmunologyVirology	2021	411
Detection of expiratory flow limitation in COPD using the forced oscillation technique Raffaele L. Dellacá, Pierachille Santus, Andréa Aliverti, European Respiratory Journal Copd BreathsHealthy SubjectsVentilationPhysiologyExercise Physiology	2004	350
Close correlation between anxiety, depression, and asthma control Fabiano Di Marco, Massimo Verga, Pierachille Santus, Respiratory Medicine AsthmaPsychological Co-morbiditiesPsychiatryMood SymptomClose Correlation	2009	192
Joint Statement on the Role of Respiratory Rehabilitation in the COVID-19 Crisis: The Italian Position Paper Michele Vitacca, Mauro Carone, Enrico Clini, Respiration Covid-19 EpidemiologyExponential GrowthJoint StatementCovid-19Hospital Medicine	2020	186
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial Tim Harrison, Pascal Chanez, Francesco Menzella, The Lancet Respiratory Medicine AsthmaSevere Eosinophilic AsthmaAllergyInflammatory Lung DiseaseAllergy Medicine	2020	168
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia Francesco Salton, Paola Confalonieri, G. Umberto Meduri, Open Forum Infectious Diseases	2020	143
The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD Mario Cazzola, Fabiano Di Marco, Pierachille Santus, Pulmonary Pharmacology & Therapeutics AsthmaMedicinePulmonary PharmacologyPharmacotherapySingle Inhaled Doses	2003	141
Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy Proposal Dejan Radovanovic, Maurizio Rizzi, Stefano Pini, Journal of Clinical Medicine Interventional PulmonologyPulmonary CareArtificial RespirationCareful TitrationCovid-19	2020	138
Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study Maurizio Viecca, Dejan Radovanovic, Giovanni B. Forleo, Pharmacological Research ThrombosisBlood PlateletPlatelet ConcentratesHematologySevere Covid-19	2020	134

Page 1